pirinixic acid has been researched along with acetylcysteine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Asp, L; Borén, J; Claesson, C; Gustafsson, M; Li, L; Lindberg, K; Lindén, D; Olofsson, SO; Oscarsson, J | 1 |
| Bates, CM; Lin, F | 1 |
| Kankaanranta, H; Leppänen, T; Moilanen, E; Paukkeri, EL; Sareila, O; Vuolteenaho, K | 1 |
1 review(s) available for pirinixic acid and acetylcysteine
| Article | Year |
|---|---|
Future strategies in the treatment of acute renal failure: growth factors, stem cells, and other novel therapies.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Atrial Natriuretic Factor; Disease Models, Animal; Heme Oxygenase-1; Hepatocyte Growth Factor; Humans; Nitric Oxide Synthase; PPAR alpha; Pyrimidines; Stem Cell Transplantation | 2005 |
3 other study(ies) available for pirinixic acid and acetylcysteine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.
Topics: Acetylcysteine; Animals; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Cell Line; Cells, Cultured; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Female; Immunoblotting; Oleic Acid; Palmitic Acid; Protein Binding; Protein Biosynthesis; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Triglycerides; Tumor Cells, Cultured | 2002 |
PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
Topics: Acetylcysteine; Animals; Butyrates; Cells, Cultured; Dose-Response Relationship, Drug; Leupeptins; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phenylurea Compounds; PPAR alpha; Proteasome Endopeptidase Complex; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT1 Transcription Factor | 2007 |